Industry litigation – Page 11
-
BusinessBrexit raises regulatory worries
Risk of doubling legal burden for industry undermines referendum’s ‘red-tape cutting’ claims
-
BusinessUS university sues Dow over pollution
Three hazardous chemicals have infiltrated campus groundwater, and the school wants Dow and others to pay for clean-up
-
BusinessLilly loses arbitration over Canadian patents
Firm had sought recompense under the Nafta trade agreement
-
BusinessEU recommends withdrawing drugs approved on unreliable data
Indian firm Micro Therapeutic Research Labs accused of misrepresenting clinical data and documentation deficiencies
-
BusinessPacBio sues Oxford Nanopore for patent infringement
Firms spar over single-molecule gene sequencing technology
-
BusinessCrispr patent ruling breaks deadlock
Both sides claim victory as board rules patents do not interfere with each other
-
Business$2bn Immunomedics–Seattle Genetics deal delayed amid shareholder infighting
Major investor venBio seeks to derail deal and replace board members
-
BusinessMerck & Co settles cancer antibody patent dispute
US firm will pay Bristol-Myers Squibb and Ono $625m plus royalties on future sales of immunotherapy
-
BusinessTeva hit with fines and patent loss
Double whammy as firm settles subsidiary pay-for-delay suit and courts invalidate patents on multiple sclerosis drug
-
BusinessUS Supreme Court denies Dow tax appeal
Request to reconsider $1bn tax deduction dismissed and penalties upheld
-
NewsVolkswagen hit by another $4.3bn in penalties
Emissions cheating scandal has led to the arrest of six senior employees at the company, just as Fiat comes under fire
-
BusinessCholesterol drug withdrawn in patent dispute
Ruling that Regeneron’s Praluent antibody infringes Amgen’s Repatha patent could stifle innovation
-
BusinessShell fined $22m for drinking water contamination
Jury rules in favour of US city of Clovis over 1,2,3-trichloropropane contamination, while rejecting punitive damages
-
BusinessIndian court revokes ban on combination drugs
Companies claim government failed to follow procedure in restricting risky medicines
-
BusinessTeva fined $520m for corruption
World’s largest generics manufacturer admits paying bribes in Russia, Ukraine and Mexico
-
BusinessDuPont found liable in third bellwether cancer case
US court orders firm to pay $2m in damages to man whose disease has been linked to contaminated water supply
-
-
BusinessUS pharma executives face bribery charges over opioid painkiller prescriptions
Insys Therapeutics chief executive and senior managers accused of running a conspiracy to bribe doctors across several states
-
BusinessPharmaceutical industry roundup of 2016
Controversial approvals and price clashes characterised 2016 in pharma
-
BusinessDeath sentence for head of Tianjin explosion firm
48 Ruihai Logistics staff and government officials also sentenced